Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

589 ARTÍCULOS , VIENDO DEL 496 AL 510

Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer's disease

Wood AHR, Chappell HF, Zulyniak MA.

Eur J Nutr. 2022 Mar;61(2):589-604. doi: 10.1007/s00394-021-02655-4. Epub 2021 Aug 15.

Novel insights into RIPK1 as a promising target for future Alzheimer's disease treatment

Li S, Qu L, Wang X, Kong L.

Pharmacol Ther. 2022 Mar;231:107979. doi: 10.1016/j.pharmthera.2021.107979. Epub 2021 Sep 2.

Is resveratrol a prospective therapeutic strategy in the co-association of glucose metabolism disorders and neurodegenerative diseases?

Ribeiro R, Santos AC, Calazans MO, De Oliveira ACP, Vieira LB.

Nutr Neurosci. 2022 Nov;25(11):2442-2457. doi: 10.1080/1028415X.2021.1972514. Epub 2021 Sep 11.

The clinical correlation of proinflammatory and anti-inflammatory biomarkers with Alzheimer disease: a meta-analysis

Anuradha U, Kumar A, Singh RK.

Neurol Sci. 2022 Jan;43(1):285-298. doi: 10.1007/s10072-021-05343-7. Epub 2021 May 25.

Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in Sydney

Sexton CE, Anstey KJ, Baldacci F, Barnum CJ, Barron AM, Blennow K, Brodaty H, Burnham S, Elahi FM, Götz J, Jeon YH, Koronyo-Hamaoui M, Landau SM, Lautenschlager NT, Laws SM, Lipnicki DM, Lu H, Masters CL, Moyle W, Nakamura A, Pasinetti GM, Rao N, Rowe C, Sachdev PS, Schofield PR, Sigurdsson EM, Smith K, Srikanth V, Szoeke C, Tansey MG, Whitmer R, Wilcock D, Wong TY, Bain LJ, Carrillo MC.

Alzheimers Dement. 2022 Jan;18(1):178-190. doi: 10.1002/alz.12380. Epub 2021 May 31.

Apathy as a Treatment Target in Alzheimer's Disease: Implications for Clinical Trials

Mortby ME, Adler L, Agüera-Ortiz L, Bateman DR, Brodaty H, Cantillon M, Geda YE, Ismail Z, Lanctôt KL, Marshall GA, Padala PR, Politis A, Rosenberg PB, Siarkos K, Sultzer DL, Theleritis C; ISTAART NPS PIA.

Am J Geriatr Psychiatry. 2022 Feb;30(2):119-147. doi: 10.1016/j.jagp.2021.06.016. Epub 2021 Jul 1.

Current directions in tau research: Highlights from Tau 2020

Sexton C, Snyder H, Beher D, Boxer AL, Brannelly P, Brion JP, Buée L, Cacace AM, Chételat G, Citron M, DeVos SL, Diaz K, Feldman HH, Frost B, Goate AM, Gold M, Hyman B, Johnson K, Karch CM, Kerwin DR, Koroshetz WJ, Litvan I, Morris HR, Mummery CJ, Mutamba J, Patterson MC, Quiroz YT, Rabinovici GD, Rommel A, Shulman MB, Toledo-Sherman LM, Weninger S, Wildsmith KR, Worley SL, Carrillo MC.

Alzheimers Dement. 2022 May;18(5):988-1007. doi: 10.1002/alz.12452. Epub 2021 Sep 28.

Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial

Lin PY, Cheng C, Satyanarayanan SK, Chiu LT, Chien YC, Chuu CP, Lan TH, Su KP.

Brain Behav Immun. 2022 Jan;99:289-298. doi: 10.1016/j.bbi.2021.10.014. Epub 2021 Oct 29.

Current progress in aptamer-based sensing tools for ultra-low level monitoring of Alzheimer's disease biomarkers

Zamanian J, Khoshbin Z, Abnous K, Taghdisi SM, Hosseinzadeh H, Danesh NM.

Biosens Bioelectron. 2022 Feb 1;197:113789. doi: 10.1016/j.bios.2021.113789. Epub 2021 Nov 14.

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation

Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, van der Flier WM, Mielke MM, Del Campo M.

Lancet Neurol. 2022 Jan;21(1):66-77. doi: 10.1016/S1474-4422(21)00361-6. Epub 2021 Nov 24.

Blood-based biomarkers of agitation in Alzheimer's disease: Advances and future prospects

Tumati S, Herrmann N, Marotta G, Li A, Lanctôt KL.

Neurochem Int. 2022 Jan;152:105250. doi: 10.1016/j.neuint.2021.105250. Epub 2021 Dec 2.

Alzheimer's disease biomarkers in Black and non-Hispanic White cohorts: A contextualized review of the evidence

Gleason CE, Zuelsdorff M, Gooding DC, Kind AJH, Johnson AL, James TT, Lambrou NH, Wyman MF, Ketchum FB, Gee A, Johnson SC, Bendlin BB, Zetterberg H.

Alzheimers Dement. 2022 Aug;18(8):1545-1564. doi: 10.1002/alz.12511. Epub 2021 Dec 6.

Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention

Mahaman YAR, Embaye KS, Huang F, Li L, Zhu F, Wang JZ, Liu R, Feng J, Wang X.

Ageing Res Rev. 2022 Feb;74:101544. doi: 10.1016/j.arr.2021.101544. Epub 2021 Dec 18.

Roles of Gut Microbiota in Pathogenesis of Alzheimer's Disease and Therapeutic Effects of Chinese Medicine

Sun YX, Jiang XJ, Lu B, Gao Q, Chen YF, Wu DB, Zeng WY, Yang L, Li HH, Yu B.

Chin J Integr Med. 2022 Nov;28(11):1048-1056. doi: 10.1007/s11655-020-3274-5. Epub 2020 Sep 1.

Galantamine beyond Alzheimer's disease-a fact or artefact?

Naguy A, Husain K, Alamiri B.

CNS Spectr. 2022 Jun;27(3):268-271. doi: 10.1017/S1092852920002229. Epub 2020 Dec 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias